Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy

Journal of Urology

Volumn 159, Issue 1, 1998, Pages 173-178

  Cadeddu, Jeffrey A ^a   Partin, Alan W ^a   DeWeese, Theodore L ^a   Walsh, Patrick C ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Prostate specific antigen; Prostatectomy; Prostatic neoplasms; Radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; COMPUTER PROGRAM; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY;

EID: 0031986351     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64047-3     Document Type: Article

References (18)

1. Partin, A. W. and Oesterling, J. E.: The clinical usefulness of prostate specific antigen: update 1994. J. Urol., 152: 1358, 1994.
2. Oesterling, J. E., Chan, D. W., Epstein, J. I., Kimball, A. W., Jr., Bruzek, D. J., Rock, R. C., Brendler, C. B. and Walsh, P. C.: Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J. Urol., 139: 766, 1988.
3. Goldrath, D. E. and Messing, E. M.: Prostate-specific antigen: not detectable despite tumor progression after radical prostatectomy. J. Urol., 142: 1082, 1989.
4. Takayama, T. K., Krieger, J. N., True, L. D. and Lange, P. H.: Recurrent prostate cancer despite undetectable prostate-specific antigen. J. Urol., 148: 1541, 1992.
5. Oefelein, M. G., Smith, N., Carter, M., Dalton, D. and Schaeffer, A.: The incidence of prostate cancer progression with undetectable serum prostate specific antigen in a series of 394 radical prostatectomies. J. Urol., 154: 2128, 1995.
6. Partin, A. W., Pound, C. R., Clemens, J. Q., Epstein, J. I. and Walsh, P. C.: Serum PSA after anatomic radical prostatectomy: the Johns Hopkins experience after 10 years. Urol. Clin. N. Amer., 20: 713, 1993.
7. Lange, P. H., Lightner, D. J., Medini, E., Reddy, P. K. and Vessella, R. L.: The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels. J. Urol., 144: 927, 1990.
8. Haab, F., Meulemans, A., Boccon-Gibod, L., Dauge, M. C., Delmas, V., Hennequin, C., Benbunan, D. and Boccon-Gibod, L.: Effect of radiation therapy after radical prostatectomy on serum prostate-specific antigen measured by an ultrasensitive assay. Urology, 45: 1022, 1995.
9. Partin A. W., Pearson, J. D., Landis, P. K., Carter, H. B., Pound, C. R., Clemens, J. Q., Epstein, J. I. and Walsh, P. C.: Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. Urology, 43: 649, 1994.
10. Morton, R. A., Steiner, M. S. and Walsh, P. C.: Cancer control following anatomical radical prostatectomy: an interim report. J. Urol., 145: 1197, 1991.
11. Takayama, T. K. and Lange, P. H.: Radiation therapy for local recurrence of prostate cancer after radical prostatectomy. Urol. Clin. N. Amer., 21: 687, 1994.
12. McCarthy, J. F., Catalona, W. J. and Hudson, M. A.: Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment. J. Urol., 151: 1575, 1994.
13. Schild, S. E., Buskirk, S. J., Wong, W. W., Halyard, M. Y., Swanson, S. K., Novicki, D. E. and Ferrigni, R. G.: The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy. J. Urol., 156: 1725, 1996.
14. Eisbruch, A., Perez, C. A., Roessler, E. H. and Lockett, M. A.: Adjuvant irradiation after prostatectomy for carcinoma of the prostate with positive surgical margins. Cancer, 73: 384, 1994.
15. Forman, J. D., Duclos, M., Shamsa, F. and Pontes, E. J.: Predicting the need for adjuvant systemic therapy in patients receiving postprostatectomy irradiation. Urology, 47: 382, 1996.
16. Wright, G. L., Haley, C., Beckett, M. L. and Schellhammer, P. F.: Expression of prostate specific membrane antigen in normal, benign, and malignant prostate tissue. Urol. Oncol., 1: 18, 1995.
17. 111indium-labeled Cyt-356 for the detection of occult prostate cancer recurrence. J. Urol., 152: 1490, 1994.
18. 111indium-labeled monoclonal antibody Cyt-356. J. Urol., 152: 1952, 1994.